Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E Gerber

Showing results (1-10 of 288) with videos related to

Pageof 29
Sort By:
American Family Physician|February 27, 2008
Targeted therapies: a new generation of cancer treatmentsDavid E Gerber
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 20, 2012
Miscellaneous agents--cytotoxics and hormonal agentsDavid E Gerber
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 6, 2023
Taking It to the States: Adapting Information Blocking Legislation to OncologyDavid E Gerber
JCO Oncology Practice|August 26, 2021
21st Century Cures Act: Implementation Without Understanding Implication?David E Gerber
Journal of Oncology Practice|January 12, 2018
Oligometastatic Non-Small-Cell Lung Cancer: How Should We Define and Manage It?David E Gerber
The Pharos of Alpha Omega Alpha-Honor Medical Society. Alpha Omega Alpha|March 1, 2013
"Pure and wholesome": Stephen Allen, cholera, and the nineteenth-century New York City water supplyDavid E Gerber
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2013
Maintenance therapy for advanced lung cancer: who, what, and when?David E Gerber
American Family Physician|August 1, 2014
Should family physicians routinely screen for lung cancer in high-risk populations? Yes: CT-based screening is complex but worthwhileDavid E Gerber
Journal of Oncology Practice|June 23, 2016
Performance Status-Based Oncology Practice Guidelines: Easier Said Than DoneDavid E Gerber
Drug Development Research|June 30, 2009
EGFR Inhibition in the Treatment of Non-Small Cell Lung CancerDavid E Gerber
Pageof 29

Showing results (1-10 of 288) with videos related to

Sort By:
Pageof 29
American Family Physician|February 27, 2008
Targeted therapies: a new generation of cancer treatmentsDavid E Gerber
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 20, 2012
Miscellaneous agents--cytotoxics and hormonal agentsDavid E Gerber
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 6, 2023
Taking It to the States: Adapting Information Blocking Legislation to OncologyDavid E Gerber
JCO Oncology Practice|August 26, 2021
21st Century Cures Act: Implementation Without Understanding Implication?David E Gerber
Journal of Oncology Practice|January 12, 2018
Oligometastatic Non-Small-Cell Lung Cancer: How Should We Define and Manage It?David E Gerber
The Pharos of Alpha Omega Alpha-Honor Medical Society. Alpha Omega Alpha|March 1, 2013
"Pure and wholesome": Stephen Allen, cholera, and the nineteenth-century New York City water supplyDavid E Gerber
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2013
Maintenance therapy for advanced lung cancer: who, what, and when?David E Gerber
American Family Physician|August 1, 2014
Should family physicians routinely screen for lung cancer in high-risk populations? Yes: CT-based screening is complex but worthwhileDavid E Gerber
Journal of Oncology Practice|June 23, 2016
Performance Status-Based Oncology Practice Guidelines: Easier Said Than DoneDavid E Gerber
Drug Development Research|June 30, 2009
EGFR Inhibition in the Treatment of Non-Small Cell Lung CancerDavid E Gerber
Pageof 29